Last updated: July 5, 2023
Sponsor: Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina
Overall Status: Active - Recruiting
Phase
N/A
Condition
N/ATreatment
systematic and structured review of patient pharmacotherapeutic treatment plans
Clinical Study ID
NCT05944328
22/191-P
Ages 65-110 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Age 65 years or older
- Pharmacological treatment with at least one drug and for a period of more than threemonths
Exclusion
Exclusion Criteria:
- Individuals who at the time of the pharmaceutical review were in hospital
- Patients nearing the end of life
- Patients whose participation was considered by the doctor responsible to bepotentially detrimental
- Patients not covered by the public healthcare or pharmacy system were excluded.
Study Design
Total Participants: 862
Treatment Group(s): 1
Primary Treatment: systematic and structured review of patient pharmacotherapeutic treatment plans
Phase:
Study Start date:
February 22, 2023
Estimated Completion Date:
June 01, 2024
Connect with a study center
Cecilia Campabadal Prats
Tarragona, 43003
SpainActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.